| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Helfand BT et al. | Consequences of switching 5alpha-reductase inhibitors on prostate specific antigen velocity. | 2010 | J. Urol. | pmid:20483154 |
| Kramer BS et al. | Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. | 2009 | J. Urol. | pmid:19249063 |
| Chai TC | Treatment of men with lower urinary tract symptoms and overactive bladder. | 2007 | JAMA | pmid:17374808 |
| Randall VA et al. | New dimensions in Hirsutism. | 2006 | Lasers Med Sci | pmid:16874541 |
| Jusakul A et al. | Mechanisms of oxysterol-induced carcinogenesis. | 2011 | Lipids Health Dis | pmid:21388551 |
| Yarrow JF et al. | Intracrine and myotrophic roles of 5α-reductase and androgens: a review. | 2012 | Med Sci Sports Exerc | pmid:21988936 |
| Cohen P | Do 5-alpha reductase inhibitors influence the severity of brain injury in men after a stroke? | 2010 | Med. Hypotheses | pmid:20202761 |
| Baudrand R et al. | Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients. | 2011 | Metab. Clin. Exp. | pmid:21704348 |
| Corradi LS et al. | Increased androgen receptor and remodeling in the prostatic stroma after the inhibition of 5-alpha reductase and aromatase in gerbil ventral prostate. | 2009 | Microsc. Res. Tech. | pmid:19484778 |
| Reismann P et al. | Pharmacological options for treatment of hyperandrogenic disorders. | 2009 | Mini Rev Med Chem | pmid:19689407 |
| Aloisi AM et al. | Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats. | 2010 | Mol Pain | pmid:20977699 |
| Torres JM et al. | Semiquantitative RT-PCR method coupled to capillary electrophoresis to study 5alpha-reductase mRNA isozymes in rat ventral prostate in different androgen status. | 2003 | Mol. Cell. Biochem. | pmid:12962150 |
| Panter BU et al. | 5alpha-reductase in human embryonic kidney cell line HEK293: evidence for type II enzyme expression and activity. | 2005 | Mol. Cell. Biochem. | pmid:15792368 |
| Hall MC | The effect of oxysterols, individually and as a representative mixture from food, on in vitro cultured bovine ovarian granulosa cells. | 2006 | Mol. Cell. Biochem. | pmid:16983501 |
| Robaire B and Henderson NA | Actions of 5alpha-reductase inhibitors on the epididymis. | 2006 | Mol. Cell. Endocrinol. | pmid:16476520 |
| Fox SA et al. | Identifying putative contraceptive targets by dissecting signal transduction networks in the epididymis using an in vivo electroporation (electrotransfer) approach. | 2006 | Mol. Cell. Endocrinol. | pmid:16423449 |
| Wu YG et al. | Testosterone, not 5α-dihydrotestosterone, stimulates LRH-1 leading to FSH-independent expression of Cyp19 and P450scc in granulosa cells. | 2011 | Mol. Endocrinol. | pmid:21273442 |
| Rosłoniec KZ et al. | Cytochrome P450 125 (CYP125) catalyses C26-hydroxylation to initiate sterol side-chain degradation in Rhodococcus jostii RHA1. | 2009 | Mol. Microbiol. | pmid:19843222 |
| Molnár I et al. | Bacterial cholesterol oxidases are able to act as flavoprotein-linked ketosteroid monooxygenases that catalyse the hydroxylation of cholesterol to 4-cholesten-6-ol-3-one. | 1993 | Mol. Microbiol. | pmid:8459768 |
| Ouellet H et al. | Mycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest-4-en-3-one. | 2010 | Mol. Microbiol. | pmid:20545858 |
| Kaul HK et al. | Genotoxicity of two fecal steroids in murine colonic epithelium assessed by the sister chromatid exchange technique. | 1987 | Mutagenesis | pmid:3328036 |
| Jusakul A et al. | Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. | 2012 | Mutat. Res. | pmid:22044627 |
| Marques MP et al. | Continuous steroid biotransformations in microchannel reactors. | 2012 | N Biotechnol | pmid:22008387 |
| Ho CK and Habib FK | Estrogen and androgen signaling in the pathogenesis of BPH. | 2011 | Nat Rev Urol | pmid:21228820 |
| Chen L et al. | A new ent-kaurane diterpenoid from Ixora amplexicaulis. | 2016 | Nat. Prod. Res. | pmid:25941744 |
| Huang YF et al. | One new anthraquinone from marine Streptomyces sp. FX-58. | 2006 | Nat. Prod. Res. | pmid:17127510 |
| Sánchez P et al. | Effects of testosterone on brain mRNA levels of steroid 5alpha-reductase isozymes in early postnatal life of rat. | 2006 | Neurochem. Int. | pmid:16828201 |
| Bortolato M et al. | Isolation rearing-induced reduction of brain 5α-reductase expression: relevance to dopaminergic impairments. | 2011 | Neuropharmacology | pmid:21256141 |
| Zoccolella S et al. | Current and emerging treatments for amyotrophic lateral sclerosis. | 2009 | Neuropsychiatr Dis Treat | pmid:19966906 |
| Ordyan NE and Pivina SG | Effects of prenatal stress on the activity of an enzyme involved in neurosteroid synthesis during the "critical period" of sexual differentiation of the brain in male rats. | 2005 | Neurosci. Behav. Physiol. | pmid:16270175 |
| Yawno T et al. | Role of neurosteroids in regulating cell death and proliferation in the late gestation fetal brain. | 2009 | Neuroscience | pmid:19591903 |
| Andersson KE | LUTS treatment: future treatment options. | 2007 | Neurourol. Urodyn. | pmid:17696154 |
| Zhou C et al. | The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. | 2009 | Nucl Recept Signal | pmid:19240808 |
| Bartram HP et al. | Effects of fish oil on fecal bacterial enzymes and steroid excretion in healthy volunteers: implications for colon cancer prevention. | 1996 | Nutr Cancer | pmid:8837863 |
| Livingstone DE et al. | Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization. | 2005 | Obes. Res. | pmid:16222053 |
| Xiao WH et al. | Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel. | 2009 | Pain | pmid:19833436 |
| Nguyen PN et al. | Changes in 5alpha-pregnane steroids and neurosteroidogenic enzyme expression in the perinatal sheep. | 2003 | Pediatr. Res. | pmid:12646725 |
| Nguyen PN et al. | Changes in 5alpha-pregnane steroids and neurosteroidogenic enzyme expression in fetal sheep with umbilicoplacental embolization. | 2003 | Pediatr. Res. | pmid:12930920 |
| Holzgrabe U and Sinz A | [Alpha blockers and 5-alpha reductase inhibitors]. | 2008 | Pharm Unserer Zeit | pmid:18615868 |
| Finn DA et al. | The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches. | 2004 | Pharmacol. Ther. | pmid:14761701 |
| Gallegos PJ and Frazee LA | Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia. | 2008 | Pharmacotherapy | pmid:18294115 |
| DuÅ¡ková M and PospÃÅ¡ilová H | The role of non-aromatizable testosterone metabolite in metabolic pathways. | 2011 | Physiol Res | pmid:21114370 |
| Pan L et al. | Sterols with antileishmanial activity isolated from the roots of Pentalinon andrieuxii. | 2012 | Phytochemistry | pmid:22840389 |
| Wollam J et al. | A novel 3-hydroxysteroid dehydrogenase that regulates reproductive development and longevity. | 2012 | PLoS Biol. | pmid:22505847 |
| Li J et al. | Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention. | 2011 | PLoS ONE | pmid:22194926 |
| Lange Y et al. | Activation mobilizes the cholesterol in the late endosomes-lysosomes of Niemann Pick type C cells. | 2012 | PLoS ONE | pmid:22276143 |
| Mouzaki M et al. | Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease. | 2016 | PLoS ONE | pmid:27203081 |
| Neuvonen M et al. | Enzymatic oxidation of cholesterol: properties and functional effects of cholestenone in cell membranes. | 2014 | PLoS ONE | pmid:25157633 |
| Bouvaine S et al. | A dietary test of putative deleterious sterols for the aphid Myzus persicae. | 2014 | PLoS ONE | pmid:24465993 |
| Le Lay S et al. | Caveolin-1-mediated apolipoprotein A-I membrane binding sites are not required for cholesterol efflux. | 2011 | PLoS ONE | pmid:21858084 |
| Sen S et al. | Restoration of IFNγR subunit assembly, IFNγ signaling and parasite clearance in Leishmania donovani infected macrophages: role of membrane cholesterol. | 2011 | PLoS Pathog. | pmid:21931549 |
| Griffin JE et al. | High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. | 2011 | PLoS Pathog. | pmid:21980284 |
| Olanrewaju HA et al. | Stress and acid-base balance in chickens. | 2006 | Poult. Sci. | pmid:16830868 |
| Schmidt LJ et al. | Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts. | 2009 | Prostate | pmid:19676081 |
| Schatzl G et al. | Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men. | 2002 | Prostate | pmid:12111704 |
| Niu Y et al. | Reduced levels of 5-α reductase 2 in adult prostate tissue and implications for BPH therapy. | 2011 | Prostate | pmid:21308715 |
| Ji Q et al. | Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. | 2003 | Prostate | pmid:12539226 |
| Assinder SJ | Oxytocin increases 5alpha-reductase activity of human prostate epithelial cells, but not stromal cells. | 2008 | Prostate | pmid:18008328 |
| Schmidt LJ et al. | Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride. | 2007 | Prostate | pmid:17477363 |
| Gupta S et al. | Inhibition of 5alpha-reductase enhances testosterone-induced expression of U19/Eaf2 tumor suppressor during the regrowth of LNCaP xenograft tumor in nude mice. | 2010 | Prostate | pmid:20564326 |
| Luo J et al. | Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma. | 2003 | Prostate | pmid:12949937 |
| Chang BL et al. | Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer. | 2003 | Prostate | pmid:12746845 |
| Shibata A et al. | Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis. | 2002 | Prostate | pmid:12210487 |
| Grinthal A and Guidotti G | CD39, NTPDase 1, is attached to the plasma membrane by two transmembrane domains. Why? | 2006 | Purinergic Signal. | pmid:18404478 |
| Rontani JF and Aubert C | Electron ionization mass spectral fragmentation of derivatized 4,5- and 5,6-epoxysterols. | 2004 | Rapid Commun. Mass Spectrom. | pmid:15116422 |
| Kuo HC and Liu HT | Therapeutic effects of add-on botulinum toxin A on patients with large benign prostatic hyperplasia and unsatisfactory response to combined medical therapy. | 2009 | Scand. J. Urol. Nephrol. | pmid:19308807 |
| Niven SJ et al. | Investigations of cholesterol transformation during sewage treatment: relevance to estrogen formation pathways? | 2001 | Sci. Total Environ. | pmid:11712607 |
| Ismail SI and Mazen IA | A study of gender outcome of Egyptian patients with 46,XY disorder of sex development. | 2010 | Sex Dev | pmid:20664246 |
| Pérez-Ornelas V et al. | New 5alpha-reductase inhibitors: in vitro and in vivo effects. | 2005 | Steroids | pmid:15763601 |
| Batta AK et al. | Chromatographic separation of putative precursors of cholestanol. | 1988 Jul-Aug | Steroids | pmid:3247666 |
| Palermo M et al. | Human Delta4-3-oxosteroid 5beta-reductase (AKR1D1) deficiency and steroid metabolism. | 2008 | Steroids | pmid:18243262 |
| Lin HS et al. | Synthesis of 4 alpha-(2-propenyl)-5,6-secocholestan-3 alpha-ol, a novel B-ring seco analog of the hypocholesterolemic agent 4 alpha-(2-propenyl)-5 alpha-cholestan-3 alpha-ol. | 1998 | Steroids | pmid:9589554 |
| Arellano Y et al. | New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors. | 2011 | Steroids | pmid:21729714 |
| Wijnberg JB and de Groot A | Synthesis and 13C-NMR analysis of 5 alpha- and 5 beta-cholestane-3,6-dione. | 1989 | Steroids | pmid:2588307 |
| Cabeza M et al. | Novel C-6 substituted and unsubstituted pregnane derivatives as 5alpha-reductase inhibitors and their effect on hamster flank organs diameter size. | 2009 | Steroids | pmid:19406144 |
| Maeda Y et al. | A simple, accurate, and sensitive assay method of dehydroepiandrosterone sulfate: application for quantitative determination in human breast cyst and duct fluids. | 2002 | Steroids | pmid:11958788 |
| Lewis JG et al. | Circulating levels of isoflavones and markers of 5alpha-reductase activity are higher in Japanese compared with New Zealand males: what is the role of circulating steroids in prostate disease? | 2005 | Steroids | pmid:16137729 |
| Dovbnya DV et al. | Microbial side-chain degradation of ergosterol and its 3-substituted derivatives: a new route for obtaining of deltanoids. | 2010 | Steroids | pmid:20385161 |
| Thevis M et al. | Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite. | 2007 | Ther Drug Monit | pmid:17417080 |
| Marszalek M and Madersbacher S | [Epidemiology of BPH and medication approaches]. | 2006 | Ther Umsch | pmid:16514964 |
| Colciago A et al. | Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 2: Effects on reproductive parameters, on sex behavior, on memory retention and on hypothalamic expression of aromatase and 5alpha-reductases in the offspring. | 2009 | Toxicol. Appl. Pharmacol. | pmid:19464308 |
| Melcangi RC and Panzica G | Steroids in the nervous system: a Pandora's box? | 2001 | Trends Neurosci. | pmid:11421230 |
| Hernandez J et al. | The potential role of cyclooxygenase-2 inhibitors and 5alpha-reductase inhibitors in the prevention of urologic conditions. | 2004 | Urol. Clin. North Am. | pmid:15123401 |
| Bühler P et al. | Comparison of gene expression in LNCaP prostate cancer cells after treatment with bicalutamide or 5-alpha-reductase inhibitors. | 2010 | Urol. Int. | pmid:20215827 |
| Platz EA | Basic Science. | 2001 | Urology | pmid:11273573 |
| Nam RK et al. | V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression. | 2001 | Urology | pmid:11164181 |
| Jeong YB et al. | Effect of discontinuation of 5alpha-reductase inhibitors on prostate volume and symptoms in men with BPH: a prospective study. | 2009 | Urology | pmid:19193422 |
| Araki M et al. | Decreased efficiency of potassium-titanyl-phosphate laser photoselective vaporization prostatectomy with long-term 5 alpha-reductase inhibition therapy: is it true? | 2007 | Urology | pmid:18068449 |
| Kim CI et al. | Long-term results of medical treatment in benign prostatic hyperplasia. | 2006 | Urology | pmid:17095071 |
| Barocas DA et al. | Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome. | 2005 | Urology | pmid:16286153 |
| Gravas S and Oelke M | Current status of 5alpha-reductase inhibitors in the management of lower urinary tract symptoms and BPH. | 2010 | World J Urol | pmid:19956956 |
| Wang X et al. | Establishment of a novel model for studying the effects of extracts of Chinese herb medicine on human type II 5alpha-reductase in vitro. | 2010 | Yakugaku Zasshi | pmid:20823678 |
| Oh CY et al. | Korean urologist's view of practice patterns in diagnosis and management of benign prostatic hyperplasia: a nationwide survey. | 2010 | Yonsei Med. J. | pmid:20191018 |
| Zhu YS and Cai LQ | Effects of male sex hormones on gender identity, sexual behavior, and cognitive function. | 2006 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:16706106 |
| Chen L et al. | [Active ingredients of Plastrum Testudinis inhibit epidermal stem cell apoptosis in serum-deprived culture]. | 2011 | Zhong Xi Yi Jie He Xue Bao | pmid:21849150 |
| Lei H et al. | [Sterols of marine bryozoan Bugula neritina from the South China Sea]. | 2011 | Zhong Yao Cai | pmid:21823470 |
| Chen DM et al. | [The relationship of serum testosterone and its related index with the metabolism syndrome in women at perimenopausal or postmenopausal periods]. | 2012 | Zhonghua Fu Chan Ke Za Zhi | pmid:22455743 |
4-Cholesten-3-one
4-Cholesten-3-one is a lipid of Sterol Lipids (ST) class. 4-cholesten-3-one is associated with abnormalities such as Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana and Xanthoma. The involved functions are known as CYP27A1activity, 25-hydroxycholesterol 7alpha-hydroxylase activity, Biochemical Pathway, Anabolism and Oxidation. 4-cholesten-3-one often locates in Mitochondria, Liver, Body tissue, Hepatic, Mitochondria and Endothelium of artery. The associated genes with 4-Cholesten-3-one are P4HTM gene, tryptones and Regulon. The related lipids are Cholestenones, 7-hydroxy-4-cholesten-3-one, cholest-4-en-3-one, 25-hydroxycholesterol and 24-hydroxycholesterol.
Cross Reference
Introduction
To understand associated biological information of 4-Cholesten-3-one, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 4-Cholesten-3-one?
4-Cholesten-3-one is suspected in Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana, Xanthoma, Rare Diseases and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Biochem. J. (1)
- J. Biol. Chem. (1)
- J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (1)
- Others (3)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with 4-Cholesten-3-one
Lipid pathways are not clear in current pathway databases. We organized associated pathways with 4-Cholesten-3-one through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 4-Cholesten-3-one?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Biol. Chem. (2)
- J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (1)
- J. Lipid Res. (1)
- Others (2)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 4-Cholesten-3-one?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 4-Cholesten-3-one?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 4-Cholesten-3-one?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 4-Cholesten-3-one?
There are no associated biomedical information in the current reference collection.